Z90.49 is a clinical status code representing the acquired absence of specific anatomical segments of the digestive system following surgical resection, trauma, or disease. This code is used to identify patients who have undergone procedures such as esophagectomy, cholecystectomy (absence of gallbladder), or specific bowel resections that are not classified under more specific codes (like Z90.3 for the stomach or Z90.41 for the pancreas). This status indicates a permanent alteration in digestive anatomy, necessitating ongoing clinical monitoring for functional changes, nutritional deficiencies, and potential complications associated with the missing organ or segment, such as altered bile metabolism or impaired transit.
Explicitly identify the specific anatomical organ or segment missing to distinguish from generalized gastrointestinal surgical history.
Example: Patient presents for follow-up 2 years post-total pancreatectomy performed for intraductal papillary mucinous neoplasm. Patient maintains status post acquired absence of the pancreas, now presenting with secondary insulin-dependent diabetes and malabsorption. Current management includes titrated insulin glargine and high-dose pancrelipase with meals.
Billing Focus: Anatomical specificity and the absence of the gallbladder or pancreas must be linked to the current clinical management plan.
Document the functional status and any replacement therapies necessitated by the organ absence.
Example: Patient with acquired absence of the gallbladder (Z90.49) following laparoscopic cholecystectomy for chronic cholecystitis. Patient reports stable digestion but continues to monitor for post-cholecystectomy syndrome symptoms. No biliary tree dilation noted on recent imaging.
Billing Focus: Clinical documentation should clarify if the absence is total or partial where applicable, though Z90.49 is often the default for specified parts not elsewhere classified.
Link the absence to the primary underlying condition that necessitated removal, such as malignancy or chronic inflammatory disease.
Example: Evaluation of patient with acquired absence of specified part of the intestine (Z90.49) following extensive small bowel resection for mesenteric ischemia. Patient currently dependent on total parenteral nutrition (TPN) with documentation of short bowel syndrome (K91.2).
Billing Focus: Ensure the diagnosis code is used to justify medical necessity for high-cost therapies like TPN or specialized enzyme replacements.
Distinguish between the absence of the organ and the presence of a transplant or prosthesis.
Example: Post-surgical review of patient with acquired absence of the pancreas (Z90.49). Note that the patient is not a candidate for pancreatic islet cell transplant at this time and remains on exogenous enzyme therapy for digestive support.
Billing Focus: Use Z90.49 only when the organ is missing and has not been replaced by a functional transplant (which would use Z94.81).
Incorporate the surgical history date and the original pathology to provide a complete longitudinal record.
Example: Patient remains status post total pancreatectomy (2021) for stage IIB pancreatic adenocarcinoma. Currently stable with acquired absence of the pancreas (Z90.49). Denies steatorrhea; compliance with Creon 36,000 units is confirmed.
Billing Focus: The date of surgery helps establish the transition from an acute post-operative code to a chronic status code.
Typically required for managing complex post-surgical patients with organ absence and multiple systemic complications like diabetes and malabsorption.
Appropriate for routine follow-up of a stable patient with an absent gallbladder or minor intestinal resection.
This procedure results in the acquired absence of the pancreas and other digestive parts coded under Z90.49.
The most common procedure leading to the acquired absence of the gallbladder, classified under Z90.49.
Results in the acquired absence of a specified part of the intestine.
Directly creates the state of total acquired absence of the pancreas.
Direct cause of the absence of a specified part of the intestine.
Used for ongoing surveillance to ensure no recurrence of disease in patients with absent digestive organs.
Required when a patient with organ absence develops life-threatening complications or severe malnourishment.
Essential for monitoring patients with an absent pancreas.